In these cancers, the mutation burden in POLE, E/Q, E/Z and E/Q/Z mutant tumors paralleled the mutation burden in the whole PANCAN cohort (compare Fig. 2b and Fig. 1c, Supplementary Figure 2A-D). The gene discussed is POLE; the disease is cancer.